In the BioHarmony Drug Report Database
Indomethacin
Indocin, Indocin Sr, Indomethacin, Tivorbex (indomethacin) is a small molecule pharmaceutical. Indomethacin was first approved as Indocin on 1982-01-01. It is used to treat ankylosing spondylitis, bursitis, gouty arthritis, inflammation, and osteoarthritis amongst others in the USA. It is known to target prostaglandin D2 receptor 2, peroxisome proliferator-activated receptor gamma, proton-coupled folate transporter, prostaglandin G/H synthase 2, prostaglandin G/H synthase 1, and aldo-keto reductase family 1 member C3. Indocin’s patent is valid until 2030-04-23 (FDA).
Trade Name
|
Indocin, Indocin Sr, Indomethacin, Tivorbex |
|---|---|
Common Name
|
indomethacin |
ChEMBL ID
|
CHEMBL6 |
Indication
|
ankylosing spondylitis, bursitis, gouty arthritis, inflammation, osteoarthritis, pain, patent ductus arteriosus, rheumatoid arthritis, tendinopathy |
Drug Class
|
Image (chem structure or protein)